Dexcom said Monday it has made Jereme Sylvain chief operating officer, expanding the executive’s role at the diabetes ...

Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new ...

The CMS is expanding the number of covered conditions under the program to include heart failure, COPD, substance use disorders and tobacco cessation.

Gaining authorization for transvaginal gynecologic procedures expands the list of indications for da Vinci SP in Europe.

By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.

The agency says the CMS and MA organizations aren’t doing enough to screen durable medical equipment providers, especially ...

The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha ...

Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.

Most medical device manufacturers start their consultation with me asking one of two questions: “Do we need a human factors ...

CEO Mike Mahoney gave more details at a Thursday investor conference, saying the company likely lost orders while its plants ...

Despite making progress restoring global operations, the device maker said in a securities filing that it is unlikely to meet ...

The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a ...